Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Tamar Geiger
Affiliation
Tel Aviv University
ORCID
Career Start Year
2000
Papers
99
H Index
43
Expertise
CM4AI Collaborator
Emma Lundberg (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36214786
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
Int J Cancer
2023
37141410
Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
Int J Cancer
2023
36658280
Publisher Correction: Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density.
Nat Methods
2023
35196484
Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.
Cell Rep
2022
35644059
MS-based technologies for untargeted single-cell proteomics.
Curr Opin Biotechnol
2022
35995681
Space in cancer biology: its role and implications.
Trends Cancer
2022
35045289
Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models.
Cell Rep
2022
33328638
Anti-tumour immunity induces aberrant peptide presentation in melanoma.
Nature
2021
33657365
Proteogenomics of glioblastoma associates molecular patterns with survival.
Cell Rep
2021
33500247
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
Cancer Res
2021
35121883
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
Nat Cancer
2021
34429328
Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity.
Cancer Res
2021
34480152
Nascent Ribo-Seq measures ribosomal loading time and reveals kinetic impact on ribosome density.
Nat Methods
2021
33246101
Distinct extracellular-matrix remodeling events precede symptoms of inflammation.
Matrix Biol
2021
33215756
Phosphoproteomics reveals novel modes of function and inter-relationships among PIKKs in response to genotoxic stress.
EMBO J
2021
33446566
Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance.
Clin Cancer Res
2021
32300104
Pleiotropic tumor suppressor functions of WWOX antagonize metastasis.
Signal Transduct Target Ther
2020
33050539
Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy.
Cells
2020
33327952
Publisher Correction: Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome.
BMC Biol
2020
32686675
PDZD8 interacts with Protrudin and Rab7 at ER-late endosome membrane contact sites associated with mitochondria.
Nat Commun
2020
32960509
Proteomic patterns associated with response to breast cancer neoadjuvant treatment.
Mol Syst Biol
2020
32649881
Across the Globe: Proteogenomic Landscapes of Lung Cancer.
Cell
2020
32614381
NF-κB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium.
Carcinogenesis
2020
30612738
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors.
Cell
2019
31780802
The landscape of tiered regulation of breast cancer cell metabolism.
Sci Rep
2019
30191963
Cell shape alteration during adipogenesis is associated with coordinated matrix cues.
J Cell Physiol
2019
31387980
Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues.
Proc Natl Acad Sci U S A
2019
31495571
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence.
Cell
2019
31353208
Systematic Detection of Amino Acid Substitutions in Proteomes Reveals Mechanistic Basis of Ribosome Errors and Selection for Translation Fidelity.
Mol Cell
2019
31537542
MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity.
Cancer Immunol Res
2019
30760538
Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
Mol Cell Proteomics
2019
30962446
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.
Nat Commun
2019
31103572
Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules.
Cell Syst
2019
31047779
Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility.
Neuron
2019
30639046
Identification of nucleolar protein NOM1 as a novel nuclear IGF1R-interacting protein.
Mol Genet Metab
2019
29149330
S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced Shock.
J Infect Dis
2018
30154156
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification.
Cancer Res
2018
30042207
The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications.
Clin Cancer Res
2018
30138580
Principles of Systems Biology, No. 31.
Cell Syst
2018
29353882
IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
Oncogene
2018
29253183
Nuclear poly(A)-binding protein 1 is an ATM target and essential for DNA double-strand break repair.
Nucleic Acids Res
2018
28736317
Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research.
Am J Pathol
2017
28460002
Proteomic analysis of polyribosomes identifies splicing factors as potential regulators of translation during mitosis.
Nucleic Acids Res
2017
28306143
Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.
J Neurochem
2017
28420336
Reduced changes in protein compared to mRNA levels across non-proliferating tissues.
BMC Genomics
2017
28674905
Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
Methods Mol Biol
2017
26725330
Proteomic maps of breast cancer subtypes.
Nat Commun
2016
26651926
The Proteome of Primary Prostate Cancer.
Eur Urol
2016
27697834
Tumor macrophages are pivotal constructors of tumor collagenous matrix.
J Exp Med
2016
28009266
Elucidation of Signaling Pathways from Large-Scale Phosphoproteomic Data Using Protein Interaction Networks.
Cell Syst
2016
1 - 50 of 99
Column Actions
Search
Recommended Authors
Alexandre R Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2019
Number of shared co-authors
0
Andrew Macklin
Margaret Cancer Center
Career Start Year
2016
Number of shared co-authors
0
Anthony J Cesnik
University of Wisconsin-Madison
Career Start Year
2015
Number of shared co-authors
4
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2015
Number of shared co-authors
0
Gian Luca Negri
British Columbia Cancer Research Institute
Career Start Year
2013
Number of shared co-authors
0
Fabian Coscia
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year
2011
Number of shared co-authors
3
Ankit Sinha
Max Planck Institute of Biochemistry
Career Start Year
2011
Number of shared co-authors
1
Nikolai Slavov
and Barnett Institute, Northeastern University
Career Start Year
2009
Number of shared co-authors
4
Vladimir Ignatchenko
Margaret Cancer Center
Career Start Year
2009
Number of shared co-authors
1
Yansheng Liu
Yale University School of Medicine
Career Start Year
2008
Number of shared co-authors
3
Alessandro Ori
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
Career Start Year
2007
Number of shared co-authors
4
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year
2006
Number of shared co-authors
1
Alex Ignatchenko
European Bioinformatics Institute (EMBL-EBI)
Career Start Year
2005
Number of shared co-authors
0
Henrik J Johansson
Karolinska Institutet
Career Start Year
2005
Number of shared co-authors
4
Bernd Bodenmiller
University of Zurich
Career Start Year
2005
Number of shared co-authors
8
Bing Zhang
Baylor College of Medicine
Career Start Year
2005
Number of shared co-authors
4
Nicholas A Graham
University of Southern California
Career Start Year
2004
Number of shared co-authors
0
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year
2004
Number of shared co-authors
0
Feng Yang
Howard Hughes Medical Institute, University of California San Diego
Career Start Year
2003
Number of shared co-authors
1
Kai St??hler
Universitatsklinikum
Career Start Year
2002
Number of shared co-authors
0
Parag Mallick
Stanford University
Career Start Year
2000
Number of shared co-authors
5
Marina A Gritsenko
Pacific Northwest National Laboratory
Career Start Year
2000
Number of shared co-authors
2
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year
2000
Number of shared co-authors
1
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year
2000
Number of shared co-authors
0
Paul Taylor
Hospital for Sick Children
Career Start Year
1999
Number of shared co-authors
1
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year
1998
Number of shared co-authors
1
Janne Lehti??
Karolinska Institutet
Career Start Year
1997
Number of shared co-authors
8
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1997
Number of shared co-authors
1
Steven P Gygi
Harvard Medical School
Career Start Year
1991
Number of shared co-authors
7
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year
1988
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Matthias Mann
Max-Planck Institute of Biochemistry
Co-authored papers
20
J??rgen Cox
Max-Planck Institute of Biochemistry
Co-authored papers
16
Eytan Ruppin
National Cancer Institute
Co-authored papers
8
Keren Levanon
Co-authored papers
4
Roded Sharan
Tel Aviv University
Co-authored papers
3
Gali Yanovich
Tel Aviv University
Co-authored papers
3
Benjamin Geiger
Co-authored papers
3
Maya Schuldiner
The Weizmann Institute of Science
Co-authored papers
2
Niko Beerenwinkel
ETH Zurich
Co-authored papers
2
Emma Lundberg (CM4AI)
Stanford University
Co-authored papers
2
Nagarjuna Nagaraj
Bruker Daltonics GmbH & Co. KG
Co-authored papers
2
Simona Cristea
Dana-Farber Cancer Institute
Co-authored papers
2
Dana Silverbush
Broad Institute of Harvard and MIT
Co-authored papers
2
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers
2
Ileana M Cristea
Princeton University
Co-authored papers
1
Ana Velic
Interfaculty Institute for Cell Biology.
Co-authored papers
1
Daniel Klevebring
Karolinska Institutet
Co-authored papers
1
Peter J Oefner
Institute of Functional Genomics, University of Regensburg
Co-authored papers
1
Michael Altenbuchinger
University Medical Center Gottingen
Co-authored papers
1
Marcus Bosenberg
Yale School of Medicine
Co-authored papers
1
Caroline Kampf
Uppsala University
Co-authored papers
1
Gerald S Shadel
Salk Institute for Biological Studies
Co-authored papers
1
Yasushi Ishihama
Graduate School of Pharmaceutical Sciences, Kyoto University
Co-authored papers
1
Rainer Spang
University of Regensburg
Co-authored papers
1
Ulrich Auf dem Keller
Technical University of Denmark
Co-authored papers
1
Oscar M Rueda
University of Cambridge
Co-authored papers
1
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Co-authored papers
1
Zhemin Zhou
Pasteurien College, Suzhou Medical College of Soochow University
Co-authored papers
1
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers
1
Fabio Vandin
University of Padova
Co-authored papers
1
1 - 30